Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
AI should not be used to predict the course of clinical depression if all it has to work with are new patients’ medical records of past diagnoses, medications, encounters and patient-reported outcomes.
AI and machine learning are adept at selecting good candidates for total joint arthroplasty and predicting which patients will and won’t experience post-op complications.
Nearly 3 million Americans gained healthcare coverage during the special enrollment period (SEP) created by President Joe Biden, the White House announced.
Expanding Medicaid is associated with better health outcomes at federally qualified health centers (FQHCs), according to a recent study published in JAMA.
Researchers in the U.S. and China have meshed AI with blood testing and CT lung imaging to accurately predict which newly diagnosed COVID-19 patients will need a mechanical ventilator.
AI has shown strong potential for predicting which recently hospitalized patients will develop pressure injuries (PIs), also known as pressure ulcers or bedsores, if they aren’t treated early with preventive medicine.
The agency is urging healthcare providers to transition away from these devices and seek out alternatives. It is even working with other manufacturers to try and get similar products on the market as quickly as possible.